Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Myovant Sciences Ltd (MYOV)

NYSE
Currency in USD
Disclaimer
26.98
0.00(0.00%)
Real-time Data

MYOV Comments

$40-45 buyout target by Sumitovant in 2-4 weeks
stock will be supported higher on next financial report I believe...
FDA APPROVED vaccines for COVID-19. Stocks dropped
FDA approval for Orgovyx in prostate cancer!
FDA approval for Orgovyx in prostate cancer!
FDA approval for Orgovyx in prostate cancer
Here we go
It will go up soon
ANY advise please for MYOVANT ? is going to rise up soon or in long term please ? best regards, Szilike.
one of the best stocks you can get right now..hurry and jump in
Dilutive share issue may be coming.
if look to left...article saying myov to receive asddl financeing from sumitomo dain...200m low interest 5 year loan.....then again they still may do an offering
start button pressed.eject.
entry point today.thanks to donald duck.
great news are coming with Santa.fearless buy and stay tuned.
get ready.30$ coming soon
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.